AKT1 and neoplasm: More strikingly, triple-combination therapy incorporating CQ with PI3K/AKT inhibitors and PTX achieves effective reversal of protective autophagy triggered by PI3K/AKT pathway inhibition and marked enhancement of tumor cell apoptosis, and potentially overcomes multiple drug resistance mechanisms [151].